1 1303 98 HATHA YOGA PRACTICE FOR TYPE 2 DIABETES MELLITUS PATIENTS: A PILOT STUDY. OBJECTIVE: THIS STUDY WAS CONDUCTED TO EXAMINE THE IMPACT OF HATHA YOGA ON GLYCEMIC CONTROL, PSYCHOLOGICAL AND PHYSIOLOGICAL STRESS, AND SELF-CARE FOR INDIVIDUALS WITH TYPE 2 DIABETES MELLITUS (T2DM). METHODS: TEN SEDENTARY INDIVIDUALS WITH T2DM WHO WERE NON-INSULIN DEPENDENT, FREE OF DIABETES-RELATED COMPLICATIONS, AND HAD NO PREVIOUS YOGA EXPERIENCE COMPLETED THERAPEUTIC YOGA CLASSES FOR 6 WEEKS, 3 TIMES PER WEEK . GLYCEMIC CONTROL MEASURES INCLUDED FASTING BLOOD GLUCOSE, GLYCATED HEMOGLOBIN, AND FASTING INSULIN. THE STATE-TRAIT ANXIETY INVENTORY, PERCEIVED STRESS SCALE, AND SALIVARY CORTISOL WERE USED TO ASSESS LEVELS OF STRESS, AND THE SUMMARY OF DIABETES SELF-CARE ACTIVITIES QUESTIONNAIRE WAS USED TO ASSESS REGIMEN ADHERENCE. RESULTS: NO SIGNIFICANT CHANGES IN GLUCOSE CONTROL OR PHYSIOLOGICAL STRESS WERE FOUND; HOWEVER, SIGNIFICANT CHANGES IN PERCEIVED STRESS, STATE ANXIETY, AND SELF-CARE BEHAVIORS WERE DETECTED. CONCLUSIONS: PRELIMINARY FINDINGS SUPPORT FURTHER INVESTIGATION OF THE BENEFITS OF HATHA YOGA AS A COMPLEMENTARY THERAPY FOR THOSE WITH T2DM. 2013 2 2353 34 UTILIZATION OF 3-MONTH YOGA PROGRAM FOR ADULTS AT HIGH RISK FOR TYPE 2 DIABETES: A PILOT STUDY. VARIOUS MODES OF PHYSICAL ACTIVITY, COMBINED WITH DIETING, HAVE BEEN WIDELY RECOMMENDED TO PREVENT OR DELAY TYPE 2 DIABETES. AMONG THESE, YOGA HOLDS PROMISE FOR REDUCING RISK FACTORS FOR TYPE 2 DIABETES BY PROMOTING WEIGHT LOSS, IMPROVING GLUCOSE LEVELS AND REDUCING BLOOD PRESSURE AND LIPID LEVELS. THIS PILOT STUDY AIMED TO ASSESS THE FEASIBILITY OF IMPLEMENTING A 12-WEEK YOGA PROGRAM AMONG ADULTS AT HIGH RISK FOR TYPE 2 DIABETES. TWENTY-THREE ADULTS (19 WHITES AND 4 NON-WHITES) WERE RANDOMLY ASSIGNED TO THE YOGA INTERVENTION GROUP OR THE EDUCATIONAL GROUP. THE YOGA GROUP PARTICIPATED IN A 3-MONTH YOGA INTERVENTION WITH SESSIONS TWICE PER WEEK AND THE EDUCATIONAL GROUP RECEIVED GENERAL HEALTH EDUCATIONAL MATERIALS EVERY 2 WEEKS. ALL PARTICIPANTS COMPLETED QUESTIONNAIRES AND HAD BLOOD TESTS AT BASELINE AND AT THE END OF 3 MONTHS. EFFECT SIZES WERE REPORTED TO SUMMARIZE THE EFFICACY OF THE INTERVENTION. ALL PARTICIPANTS ASSIGNED TO THE YOGA INTERVENTION COMPLETED THE YOGA PROGRAM WITHOUT COMPLICATION AND EXPRESSED HIGH SATISFACTION WITH THE PROGRAM (99.2%). THEIR YOGA SESSION ATTENDANCE RANGED FROM 58.3 TO 100%. COMPARED WITH THE EDUCATION GROUP, THE YOGA GROUP EXPERIENCED IMPROVEMENTS IN WEIGHT, BLOOD PRESSURE, INSULIN, TRIGLYCERIDES AND EXERCISE SELF-EFFICACY INDICATED BY SMALL TO LARGE EFFECT SIZES. THIS PRELIMINARY STUDY INDICATES THAT A YOGA PROGRAM WOULD BE A POSSIBLE RISK REDUCTION OPTION FOR ADULTS AT HIGH RISK FOR TYPE 2 DIABETES. IN ADDITION, YOGA HOLDS PROMISE AS AN APPROACH TO REDUCING CARDIOMETABOLIC RISK FACTORS AND INCREASING EXERCISE SELF-EFFICACY FOR THIS GROUP. 2011 3 247 45 A YOGA INTERVENTION FOR TYPE 2 DIABETES RISK REDUCTION: A PILOT RANDOMIZED CONTROLLED TRIAL. BACKGROUND: TYPE 2 DIABETES IS A MAJOR HEALTH PROBLEM IN MANY COUNTRIES INCLUDING INDIA. YOGA MAY BE AN EFFECTIVE TYPE 2 DIABETES PREVENTION STRATEGY IN INDIA, PARTICULARLY GIVEN ITS CULTURAL FAMILIARITY. METHODS: THIS WAS A PARALLEL, RANDOMIZED CONTROLLED PILOT STUDY TO COLLECT FEASIBILITY AND PRELIMINARY EFFICACY DATA ON YOGA FOR DIABETES RISK FACTORS AMONG PEOPLE AT HIGH RISK OF DIABETES. PRIMARY OUTCOMES INCLUDED: CHANGES IN BMI, WAIST CIRCUMFERENCE, FASTING BLOOD GLUCOSE, POSTPRANDIAL BLOOD GLUCOSE, INSULIN, INSULIN RESISTANCE, BLOOD PRESSURE, AND CHOLESTEROL. WE ALSO LOOKED AT MEASURES OF PSYCHOLOGICAL WELL-BEING INCLUDING CHANGES IN DEPRESSION, ANXIETY, POSITIVE AND NEGATIVE AFFECT AND PERCEIVED STRESS. FORTY-ONE PARTICIPANTS WITH ELEVATED FASTING BLOOD GLUCOSE IN BANGALORE, INDIA WERE RANDOMIZED TO EITHER YOGA (N = 21) OR A WALKING CONTROL (N = 20). PARTICIPANTS WERE ASKED TO EITHER ATTEND YOGA CLASSES OR COMPLETE MONITORED WALKING 3-6 DAYS PER WEEK FOR EIGHT WEEKS. RANDOMIZATION AND ALLOCATION WAS PERFORMED USING COMPUTER-GENERATED RANDOM NUMBERS AND GROUP ASSIGNMENTS DELIVERED IN SEALED, OPAQUE ENVELOPES GENERATED BY OFF-SITE STUDY STAFF. DATA WERE ANALYZED BASED ON INTENTION TO TREAT. RESULTS: THIS STUDY WAS FEASIBLE IN TERMS OF RECRUITMENT, RETENTION AND ADHERENCE. IN ADDITION, YOGA PARTICIPANTS HAD SIGNIFICANTLY GREATER REDUCTIONS IN WEIGHT, WAIST CIRCUMFERENCE AND BMI VERSUS CONTROL (WEIGHT -0.8 +/- 2.1 VS. 1.4 +/- 3.6, P = 0.02; WAIST CIRCUMFERENCE -4.2 +/- 4.8 VS. 0.7 +/- 4.2, P < 0.01; BMI -0.2 +/- 0.8 VS. 0.6 +/- 1.6, P = 0.05). THERE WERE NO BETWEEN GROUP DIFFERENCES IN FASTING BLOOD GLUCOSE, POSTPRANDIAL BLOOD GLUCOSE, INSULIN RESISTANCE OR ANY OTHER FACTORS RELATED TO DIABETES RISK OR PSYCHOLOGICAL WELL-BEING. THERE WERE SIGNIFICANT REDUCTIONS IN SYSTOLIC AND DIASTOLIC BLOOD PRESSURE, TOTAL CHOLESTEROL, ANXIETY, DEPRESSION, NEGATIVE AFFECT AND PERCEIVED STRESS IN BOTH THE YOGA INTERVENTION AND WALKING CONTROL OVER THE COURSE OF THE STUDY. CONCLUSION: AMONG INDIANS WITH ELEVATED FASTING BLOOD GLUCOSE, WE FOUND THAT PARTICIPATION IN AN 8-WEEK YOGA INTERVENTION WAS FEASIBLE AND RESULTED IN GREATER WEIGHT LOSS AND REDUCTION IN WAIST CIRCUMFERENCE WHEN COMPARED TO A WALKING CONTROL. YOGA OFFERS A PROMISING LIFESTYLE INTERVENTION FOR DECREASING WEIGHT-RELATED TYPE 2 DIABETES RISK FACTORS AND POTENTIALLY INCREASING PSYCHOLOGICAL WELL-BEING. TRIAL REGISTRATION: CLINICALTRIALS.GOV IDENTIFIED NCT00090506. 2014 4 2452 45 YOGA AS A COMPLEMENTARY THERAPY FOR ADULTS WITH TYPE 2 DIABETES: DESIGN AND RATIONALE OF THE HEALTHY, ACTIVE, AND IN CONTROL (HA1C) STUDY. DIABETES IS THE SEVENTH LEADING CAUSE OF DEATH IN THE UNITED STATES. FOR MOST PATIENTS, MEDICATION ALONE IS NOT SUFFICIENT TO ACHIEVE GLYCEMIC CONTROL; ATTENTION MUST ALSO BE PAID TO MULTIPLE HEALTHY BEHAVIORS INCLUDING DIET, REGULAR PHYSICAL ACTIVITY, AND STRESS MANAGEMENT. YOGA, A MINDFULNESS PRACTICE WITH EMPHASIS ON RELAXATION, MEDITATION, AND DEEP BREATHING, MAY HAVE SPECIAL RELEVANCE TO PEOPLE WITH TYPE 2 DIABETES MELLITUS (T2DM). YOGA PRACTICE MAY POSITIVELY AFFECT STRESS AND OTHER SELF-CARE TASKS THAT WILL CONTRIBUTE TO IMPROVED GLYCEMIC CONTROL. THE HEALTHY, ACTIVE, AND IN CONTROL (HA1C) STUDY IS DESIGNED TO EXAMINE THE FEASIBILITY AND ACCEPTABILITY OF YOGA AMONG ADULT PATIENTS WITH T2DM. IN THIS PILOT RANDOMIZED CONTROLLED TRIAL, ADULTS WITH T2DM WERE RANDOMLY ASSIGNED TO EITHER A 12-WEEK IYENGAR YOGA INTERVENTION GIVEN TWICE WEEKLY, OR A TWICE-WEEKLY 12-WEEK PROGRAM OF TRADITIONAL EXERCISE (E.G., WALKING, STATIONARY CYCLING). ASSESSMENTS ARE CONDUCTED AT THE END OF TREATMENT (12 WEEKS) AND AT 3 AND 6 MONTHS POSTINTERVENTION. THE HA1C STUDY WILL ASSESS FEASIBILITY AND ACCEPTABILITY (E.G., ATTENDANCE/RETENTION RATES, SATISFACTION WITH PROGRAM), GLYCEMIC OUTCOMES (E.G., HBA1C, FASTING BLOOD GLUCOSE, POSTPRANDIAL BLOOD GLUCOSE), AND CHANGES IN PHYSIOLOGICAL (E.G., SALIVARY CORTISOL) AND BEHAVIORAL FACTORS (E.G., PHYSICAL ACTIVITY, DIET) RELEVANT TO THE MANAGEMENT OF T2DM. FOCUS GROUPS ARE CONDUCTED AT THE END OF THE INTERVENTION TO EXPLORE PARTICIPANTS' EXPERIENCE WITH THE PROGRAM AND THEIR PERCEPTION OF THE POTENTIAL UTILITY OF YOGA FOR DIABETES MANAGEMENT. 2018 5 1378 38 IMPACT OF INDIVIDUALIZED YOGA THERAPY ON PERCEIVED QUALITY OF LIFE PERFORMANCE ON COGNITIVE TASKS AND DEPRESSION AMONG TYPE II DIABETIC PATIENTS. CONTEXT: AN INDIVIDUALIZED APPROACH OF PROVIDING YOGA SUPPORT CAN ADDRESS MANY OF THE DISEASE-RELATED CONCERNS INDICATED IN THE MANAGEMENT OF DIABETES, SPECIFICALLY THE IMPACT ON OTHER LIFE ACTIVITIES AND LONG-TERM FUNCTIONAL WELLBEING. AIM: TO ANALYZE THE ROLE OF REGULAR YOGA PRACTICE AS A SELF-MANAGEMENT APPROACH TO ACHIEVE GLYCEMIC CONTROL AND PSYCHOLOGICAL WELLBEING IN TYPE II DIABETIC PATIENTS. METHODS: NINETY-ONE SUBJECTS OF BOTH SEXES RESPONDED TO THE ANNOUNCEMENT AND CONSENTED TO PARTICIPATE IN THE STUDY. THIS WAS A SINGLE GROUP, BEFORE AND AFTER YOGA EVALUATION WITHOUT CONTROL COMPARISON. THE FASTING AND POSTPRANDIAL BLOOD SUGAR, GLYCOSYLATED HEMOGLOBIN (HBA1C), COGNITIVE TASKS, DEPRESSION, COGNITIVE FAILURE, AND DIABETIC-RELATED QUALITY OF LIFE (QOL) WERE MEASURED AS PRETEST. THE SUBJECTS UNDERWENT ONE-TO-ONE INDIVIDUALIZED YOGA THERAPY SESSIONS, WHICH INCLUDED 12 SUPERVISED SESSIONS SPREAD OVER A 3-MONTH PERIOD. THE POSTTEST DATA WERE ANALYZED USING PAIRED T-TEST AND WILCOXON PAIRED RANK TEST. RESULTS: SHOWED SIGNIFICANT REDUCTION IN FASTING BLOOD SUGAR. QOL OF THE DIABETIC PATIENTS HAD IMPROVED SIGNIFICANTLY. THERE WAS A SIGNIFICANT REDUCTION IN THE FREQUENCY (MEAN DIFFERENCE OF 7.58, P > 0.01) OF DEPRESSIVE SYMPTOMS AND INTENSITY OF DEPRESSION (MEAN DIFFERENCE 1.66, P > 0.05). CONCENTRATION AND ATTENTION SPAN IMPROVED SIGNIFICANTLY AND MEAN DISCREPANCY SCORE REDUCED (MEAN DIFFERENCE 3.42, P > 0.01). THERE WERE NO MARKED CHANGES IN THE POSTPRANDIAL BLOOD SUGAR AND HBA1C. CONCLUSION: YOGA PRACTICE ENHANCES THE SUBJECTIVE WELLBEING, QOL, IMPROVES MOOD AND CONCENTRATION, AND FACILITATES ACHIEVEMENT OF ADEQUATE GLYCEMIC CONTROL AMONG TYPE II DIABETIC PATIENTS. 2016 6 283 39 ADHERENCE TO YOGA AND ITS RESULTANT EFFECTS ON BLOOD GLUCOSE IN TYPE 2 DIABETES: A COMMUNITY-BASED FOLLOW-UP STUDY. AIM: TO STUDY THE ADHERENCE TO YOGA AND ITS EFFECTS ON BLOOD GLUCOSE PARAMETERS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. METHODS: A SINGLE GROUP LONGITUDINAL STUDY OVER 6 MONTHS WAS CONDUCTED AT VASK YOGA CENTRE, BANGALORE. FASTING BLOOD SUGAR, POST PRANDIAL BLOOD SUGAR LEVELS AND GLYCOSYLATED HEMOGLOBIN AND QUALITATIVE IN-DEPTH INTERVIEW OF THE PARTICIPANTS AND THERAPIST WAS CONDUCTED AT BASELINE, END OF 3(RD) MONTH AND END OF 6 MONTHS; INTERMEDIATE OBSERVATIONS WAS CONDUCTED AT THE END OF EVERY MONTH. RESULTS: ADHERENCE TO YOGA IN THE COMMUNITY IN BANGALORE IS AROUND 50% OVER 6 MONTHS. PARTICIPANTS WHO COMPLETED THE YOGA PROGRAMME HAD SIGNIFICANTLY LOWER HBA1C (END OF 3(RD) MONTH). AT THE END OF 6 MONTHS YOGA ADHERENCE WAS SIGNIFICANTLY NEGATIVELY CORRELATED WITH FBS AND STRESS. FURTHER THERE WAS A TREND TOWARDS THOSE WHO DROPPED OUT HAVING HIGHER FBS, CONTROLLING FOR MEDICATION INTAKE, STRESS LEVELS AND DIET PATTERN (OR = 1.027, P = 0.07). QUALITATIVE DATA REVEALED THAT MOST OF THE PARTICIPANTS JOINED AND COMPLETED THE YOGA PROGRAMME TO HELP CURE THEIR DIABETES. PARTICIPANTS WHO DROPPED OUT FROM THE YOGA PROGRAMME GAVE REASONS OF TRAVEL, ILL-HEALTH AND INCREASED WORK-LOAD AT OFFICE. CONCLUSIONS: ADHERENCE TO YOGA HAS AN EFFECT ON THE BLOOD GLUCOSE PARAMETERS IN DIABETES. HENCE, STRATEGIES TO MOTIVATE PARTICIPANTS TO UNDERGO 'LIFESTYLE MODIFICATION PRACTICES' INCLUDING MAXIMIZING ADHERENCE TO YOGA SHOULD BE THE FOCUS TO EXPERIENCE ANY BENEFICIAL EFFECTS OF YOGA. 2017 7 810 40 EFFECT OF YOGA ON BLOOD GLUCOSE LEVELS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. INTRODUCTION: IN VIEW OF PEOPLE EMBRACING SEDENTARY LIFE STYLE, AND THE EFFECTIVENESS OF TREATMENT BECOMING LESS, THE ROLE OF REGULAR EXERCISE ESPECIALLY 'YOGA' SEEMS TO BE A BENEFICIAL AND ECONOMICAL ADJUVANT IN THE MANAGEMENT OF THE TYPE 2 DIABETES MELLITUS (T2DM). OBJECTIVES: TO ASSESS THE BENEFICIAL EFFECTS OF YOGA ON BLOOD GLUCOSE LEVELS IN NORMAL AND T2DM VOLUNTEERS. MATERIALS AND METHODS: A PROSPECTIVE CASE-CONTROL STUDY WAS CONDUCTED IN THE DEPARTMENT OF PHYSIOLOGY AND DIABETIC CLINIC OF A TERTIARY CARE TEACHING HOSPITAL OVER PERIOD OF TWO YEARS. THE STUDY SUBJECTS CONSISTED OF 30 MALE DIABETIC PATIENTS ATTENDING DIABETIC CLINIC AND 30 NON-DIABETIC MALE VOLUNTEERS CONSTITUTED CONTROL GROUP. THE PATIENTS IN THE AGE GROUP OF 36 TO 55 YEARS WITH T2DM OF AT LEAST ONE YEAR DURATION AND THOSE ON DIABETIC DIET AND ORAL HYPOGLYCEMIC AGENTS WERE INCLUDED IN THE STUDY GROUP. THE AGE MATCHED HEALTHY MALE VOLUNTEERS WHO HAD COME TO JOIN YOGA TRAINING AT YOGA CENTRE WERE INCLUDED IN THE CONTROL GROUP. ALL THE PARTICIPANTS WERE TRAINED BY YOGA EXPERTS AND SUBJECTED TO REGULAR PRACTICE UNDER SUPERVISION FOR SIX MONTHS. IN ALL THE PARTICIPANTS FASTING (FBS) AND POST-PRANDIAL BLOOD SUGAR (PPBS) WAS ESTIMATED BEFORE, DURING (AT THREE MONTHS) AND AFTER (SIX MONTHS) YOGA TRAINING. PAIRED STUDENT T-TEST WAS USED TO ESTIMATE DIFFERENCE IN MEANS CALCULATED BEFORE AND AFTER YOGA TRAINING IN A SAME GROUP. A P-VALUE OF <0.05 WAS CONSIDERED AS STATISTICALLY SIGNIFICANT. RESULTS: THE DISTRIBUTION OF AGE, MEAN HEIGHT AND MEAN WEIGHT AMONG BOTH THE GROUPS WERE COMPARABLE. THE REDUCTION IN MEAN VALUES OF FBS AND PPBS AT THE END OF SIX MONTHS WAS HIGHLY SIGNIFICANT (P <0.001) IN BOTH THE GROUPS WHEN COMPARED WITH THE MEAN VALUES BEFORE AND DURING (THREE MONTHS) YOGA PRACTICE. THE REDUCTION IN THESE VALUES AT THREE MONTHS DURING YOGA WAS HIGHLY SIGNIFICANT IN T2DM GROUP WHEN COMPARED WITH MEAN VALUES BEFORE YOGA (P <0.001), BUT IT WAS INSIGNIFICANT (P<0.05) IN CONTROL GROUP. CONCLUSION: THE RESULTS OF THE PRESENT STUDY DEMONSTRATED THAT THE YOGA IS EFFECTIVE IN REDUCING THE BLOOD GLUCOSE LEVELS IN PATIENTS WITH T2DM. 2015 8 685 35 EFFECT OF AN INTEGRATED NATUROPATHY AND YOGA PROGRAM ON LONG-TERM GLYCEMIC CONTROL IN TYPE 2 DIABETES MELLITUS PATIENTS: A PROSPECTIVE COHORT STUDY. AIM: LIFESTYLE IS AN IMPORTANT RISK FACTOR FOR INCREASING THE PREVALENCE OF DIABETES IN THE INDIAN POPULATION. IN THIS STUDY, WE EVALUATE THE EFFECTS OF NATUROPATHY TREATMENT, SALT-RESTRICTED LOW-CALORIE DIETS, AND YOGA IN LONG-TERM GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. METHODS: IN THIS PROSPECTIVE, LONGITUDINAL, TWO-ARM COHORT STUDY, PATIENTS WITH TYPE 2 DIABETES MELLITUS REFERRED FROM A TERTIARY CARE CENTER UNDERGOING A 3-MONTH RESIDENTIAL NATUROPATHY TREATMENT WERE COMPARED WITH THOSE UNDERGOING ONLY CONVENTIONAL MANAGEMENT ON GLYCEMIC CONTROL. BOTH FASTING AND POSTPRANDIAL BLOOD GLUCOSE (PPBG) LEVELS WERE ASSESSED AT BASELINE, 3 MONTHS FOLLOWING INTERVENTION, AT 6 MONTHS, AND 12 MONTHS FROM THE STUDY START. DATA WERE ANALYZED USING REPEATED-MEASURES ANOVA WITH POST HOC BONFERRONI CORRECTION. RESULTS: NATUROPATHY AND YOGA INTERVENTION SIGNIFICANTLY REDUCED PPBG LEVELS (P < 0.001), GLYCATED HEMOGLOBIN LEVELS (P < 0.001), AND REDUCED REQUIREMENT FOR ANTIDIABETIC MEDICATIONS (P < 0.008) IN THE INTERVENTION GROUP COMPARED TO CONTROLS. THE EFFECTS WERE MORE PROFOUND IMMEDIATELY FOLLOWING INTERVENTION AND LASTED UP TO 6 MONTHS FROM THE START OF THE STUDY. CONCLUSION: THE RESULTS SUGGEST BENEFIT WITH AN INTENSIVE RESIDENTIAL NATUROPATHY-BASED LIFESTYLE INTERVENTION PROGRAM. RANDOMIZED CONTROLLED TRIALS ARE NEEDED TO FURTHER VALIDATE THE FINDINGS. 2020 9 1707 33 PATTERNS OF YOGA PRACTICE AND PHYSICAL ACTIVITY FOLLOWING A YOGA INTERVENTION FOR ADULTS WITH OR AT RISK FOR TYPE 2 DIABETES. BACKGROUND: THE CURRENT STUDY DESCRIBED PATTERNS OF YOGA PRACTICE AND EXAMINED DIFFERENCES IN PHYSICAL ACTIVITY OVER TIME BETWEEN INDIVIDUALS WITH OR AT RISK FOR TYPE 2 DIABETES WHO COMPLETED AN 8-WEEK YOGA INTERVENTION COMPARED WITH CONTROLS. METHODS: A LONGITUDINAL COMPARATIVE DESIGN MEASURED THE EFFECT OF A YOGA INTERVENTION ON YOGA PRACTICE AND PHYSICAL ACTIVITY, USING DATA AT BASELINE AND POSTINTERVENTION MONTHS 3, 6, AND 15. RESULTS: DISPARATE PATTERNS OF YOGA PRACTICE OCCURRED BETWEEN INTERVENTION AND CONTROL PARTICIPANTS OVER TIME, BUT THE SUBJECTIVE DEFINITION OF YOGA PRACTICE LIMITS INTERPRETATION. MULTILEVEL MODEL ESTIMATES INDICATED THAT TREATMENT GROUP DID NOT HAVE A SIGNIFICANT INFLUENCE IN THE RATE OF CHANGE IN PHYSICAL ACTIVITY OVER THE STUDY PERIOD. WHILE AGE AND EDUCATION WERE NOT SIGNIFICANT INDIVIDUAL PREDICTORS, THE INCLUSION OF THESE VARIABLES IN THE MODEL DID IMPROVE FIT. CONCLUSIONS: FINDINGS INDICATE THAT AN 8-WEEK YOGA INTERVENTION HAD LITTLE EFFECT ON PHYSICAL ACTIVITY OVER TIME. FURTHER RESEARCH IS NECESSARY TO EXPLORE THE INFLUENCE OF YOGA ON BEHAVIORAL HEALTH OUTCOMES AMONG INDIVIDUALS WITH OR AT RISK FOR TYPE 2 DIABETES. 2012 10 1104 31 EFFECTS OF YOGA VERSUS SHAM YOGA ON OXIDATIVE STRESS, GLYCEMIC STATUS, AND ANTHROPOMETRY IN TYPE 2 DIABETES MELLITUS: A SINGLE-BLINDED RANDOMIZED PILOT STUDY. STUDIES HAVE SHOWN A BENEFICIAL ROLE OF YOGA IN TRE A T I N G TYPE 2 DIABETES MELLITUS. THE PRESENT STUDY PROCEEDS IN THE FIELD BY PROVIDING AN ACTIVE CONTROL. WE AIMED TO EVALUATE THE EFFECT OF 3 MONTHS OF YOGA ON OXIDATIVE STRESS, GLYCEMIC STATUS, AND ANTHROPOMETRY IN TYPE 2 DIABETES MELLITUS. FORTY PARTICIPANTS WERE RANDOMIZED TO RECEIVE EITHER YOGA (N = 20) OR SHAM YOGA (N = 20) AS A CONTROL. YOGA INCLUDED POSTURES AND BREATHING EXERCISES, AND NONAEROBIC STRETCHING EXERCISE COMPRISED THE CONTROL. SIGNIFICANT WITHIN-GROUP DIFFERENCES IN MALONDIALDEHYDE, VITAMIN C, SUPEROXIDE DISMUTASE, FASTING BLOOD GLUCOSE, GLYCOSYLATED HEMOGLOBIN, BODY MASS INDEX, WAIST CIRCUMFERENCE, AND BLOOD PRESSURE WERE EVIDENT IN BOTH GROUPS. YOGA PARTICIPANTS HAD SIGNIFICANTLY GREATER IMPROVEMENT IN REDUCED GLUTATHIONE COMPARED TO CONTROLS. NO SIGNIFICANT DIFFERENCES BETWEEN GROUPS WERE OBSERVED IN ANY OTHER OUTCOME VARIABLES. YOGA AND SHAM YOGA HAD IDENTICAL EFFECTS ON OXIDATIVE STRESS, GLYCEMIC STATUS, AND ANTHROPOMETRY IN TYPE 2 DIABETES MELLITUS. LEVELS OF REDUCED GLUTATHIONE IMPROVED ONLY IN THE YOGA GROUP. THIS RESEARCH NEEDS TO BE CONFIRMED BY LARGER AND SUFFICIENTLY POWERED STUDIES. 2020 11 2834 28 YOGA'S EFFECT ON INFLAMMATORY BIOMARKERS AND METABOLIC RISK FACTORS IN A HIGH RISK POPULATION - A CONTROLLED TRIAL IN PRIMARY CARE. BACKGROUND: YOGA CAN REDUCE BLOOD PRESSURE AND HAS ALSO BEEN SUGGESTED TO REDUCE INFLAMMATORY BIOMARKERS AND METABOLIC RISK FACTORS FOR CARDIOVASCULAR DISEASES (CVDS). WE AIMED TO ASSESS THE BENEFIT OF TWO YOGA INTERVENTIONS ON INFLAMMATORY BIOMARKERS AND METABOLIC RISK FACTORS IN A HIGH RISK POPULATION IN PRIMARY CARE. METHODS: ADULT PATIENTS FROM A HEALTH CARE CENTER IN SWEDEN, WITH DIAGNOSED HYPERTENSION, WERE INVITED TO UNDERGO A BASELINE CHECK AT THE HEALTH CARE CENTER. BASELINE CHECK INCLUDED STANDARDIZED BLOOD PRESSURE MEASUREMENT, BMI AND WEIGHT CIRCUMFERENCE MEASUREMENTS, BLOOD SAMPLING (HS-CRP, IL-6, FP-GLUCOSE, HBA1C, CHOLESTEROL, TG, LDL AND HDL) AND A QUESTIONNAIRE ON SELF-RATED QUALITY OF LIFE (WHOQOL-BREF). THERE WERE THREE GROUPS: 1) YOGA CLASS WITH YOGA INSTRUCTOR; 2) YOGA AT HOME; AND 3) A CONTROL GROUP. IN TOTAL, 83 PATIENTS WERE INCLUDED AND MATCHED AT THE GROUP LEVEL FOR SYSTOLIC BLOOD PRESSURE. A MAJORITY OF THE PATIENTS (92 %) WERE ON ANTIHYPERTENSIVE MEDICATION, WHICH THEY WERE REQUESTED NOT TO CHANGE DURING THE STUDY. AFTER 12 WEEKS OF INTERVENTION, THE ASSESSMENTS WERE PERFORMED AGAIN. RESULTS: WE RECORDED NO EVIDENCE THAT YOGA ALTERED INFLAMMATORY BIOMARKERS OR METABOLIC RISK FACTORS IN OUR STUDY POPULATION. A TOTAL OF 49 PARTICIPANTS (59 %) MET THE CRITERIA FOR METABOLIC SYNDROME. CONCLUSION: THE YOGA INTERVENTIONS PERFORMED IN OUR STUDY DID NOT AFFECT INFLAMMATORY BIOMARKERS OR METABOLIC RISK FACTORS ASSOCIATED WITH CVD IN THE STUDY POPULATION OF PRIMARY CARE PATIENTS WITH HYPERTENSION. FURTHER RANDOMIZED TRIALS ARE NEEDED TO ELUCIDATE THE EFFECTS OF YOGA ON CVD RISK FACTORS IN THIS PARTICULAR GROUP. TRAIL REGISTRATION: NCT01302535 , FEBRUARY 22, 2011. 2015 12 762 38 EFFECT OF SUDARSHAN KRIYA YOGA ON ANXIETY, DEPRESSION, AND QUALITY OF LIFE IN PEOPLE WITH TYPE 2 DIABETES: A PILOT STUDY IN KUWAIT. AIM: THIS PILOT STUDY IN KUWAIT WAS AIMED TO ASSESS THE EFFECT OF SUDARSHAN KRIYA YOGA (SKY) ON ANXIETY, DEPRESSION AND TOTAL QUALITY OF LIFE IN PEOPLE WITH TYPE 2 DIABETES MELLITUS (T2DM). METHODS: 26 T2DM PATIENTS AGED GREATER THAN 30, MALE AND FEMALE VISITING THE OUTPATIENT CLINIC OF DASMAN DIABETES INSTITUTE WERE ENROLLED FOR THE STUDY. PRE AND POST 5 DAY SKY INTERVENTION RESPONSES OF PARTICIPANTS ON PSYCHOSOCIAL PROBLEMS WERE EVALUATED USING FOUR QUESTIONNAIRES (HAMILTON ANXIETY, PATIENT HEALTH QUESTIONNAIRE (PHQ-9), HOSPITAL ANXIETY DEPRESSION AND WHO TOTAL QUALITY OF LIFE (QOL). BIOCHEMICAL PARAMETERS; SUCH AS LIPID PROFILE, GLYCATED HEMOGLOBIN (HBA1C) WERE MEASURED AT BASELINE AND AFTER 15 WEEKS OF SKY PRACTICE. RESULTS: THE MEAN AGE OF THE PARTICIPANTS WAS 56.7 (+/-11.4 SD) YEARS, AND MEAN DURATION OF DIABETES 15.0 (+/-9.3 SD) YEARS. COMPARISON OF RESPONSES BEFORE AND AFTER INTERVENTION INDICATED A SIGNIFICANT IMPROVEMENT IN THE QOL, DEPRESSION, ANXIETY AND INSOMNIA. BUT NO SIGNIFICANT IMPROVEMENT IN GLYCEMIC CONTROL. CONCLUSION: RESULTS INDICATE THAT SKY CAN BE POTENTIALLY BENEFICIAL FOR TREATING ANXIETY, INSOMNIA, AND DEPRESSION ASSOCIATED IN PEOPLE WITH T2DM AND IN IMPROVING THE QUALITY OF LIFE IN PEOPLE WITH T2DM. 2019 13 1402 35 IMPACT OF YOGA ON BLOOD PRESSURE AND QUALITY OF LIFE IN PATIENTS WITH HYPERTENSION - A CONTROLLED TRIAL IN PRIMARY CARE, MATCHED FOR SYSTOLIC BLOOD PRESSURE. BACKGROUND: MEDICAL TREATMENT OF HYPERTENSION IS NOT ALWAYS SUFFICIENT TO ACHIEVE BLOOD PRESSURE CONTROL. DESPITE THIS, PREVIOUS STUDIES ON SUPPLEMENTARY THERAPIES, SUCH AS YOGA, ARE RELATIVELY FEW. WE INVESTIGATED THE EFFECTS OF TWO YOGA INTERVENTIONS ON BLOOD PRESSURE AND QUALITY OF LIFE IN PATIENTS IN PRIMARY HEALTH CARE DIAGNOSED WITH HYPERTENSION. METHODS: ADULT PATIENTS (AGE 20-80 YEARS) WITH DIAGNOSED HYPERTENSION WERE IDENTIFIED BY AN ELECTRONIC CHART SEARCH AT A PRIMARY HEALTH CARE CENTER IN SOUTHERN SWEDEN. IN TOTAL, 83 SUBJECTS WITH BLOOD PRESSURE VALUES OF 120-179/